Jan 25, 2025, 12:41 | Science

Erman Akkus: Review on familial multiple myeloma

Erman Akkus, Medical Oncology Fellow at Ankara University, shared a recent article by him and…

Jan 24, 2025, 02:51 | Blog

ESMO Oncogene-addicted mNSCLC Living Guideline v1.2

ESMO - European Society for Medical Oncology shared a post on LinkedIn: "Just updated: ESMO…

Jan 23, 2025, 20:46 | Drugs

Tiragolumab plus Atezolizumab and chemotherapy failed to improve OS in non-squamous NSCLC - ESMO

ESMO shared on LinkedIn: "First-line combination of tiragolumab plus atezolizumab and chemotherapy failed to improve…

Jan 21, 2025, 06:35 | Blog

Leading experts reviewing practice-changing publications in HCC and stage III melanoma - ESMO

European Society for Medical Oncology shared a post on LinkedIn: "Practice-changing publications in HCC and…

Jan 20, 2025, 17:20 | Blog

Florian Lordick: Exploring the Pathway: New Insights in Gastrointestinal Oncology

Florian Lordick, Oncologist, Professor of Medicine at University of Leipzig, posted the following on LinkedIn:…

Jan 17, 2025, 13:14 | Insight

Rasha Aboelhassan: Proud to participate in ESMO Resilience Workshop 2025

Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital, shared a post on LinkedIn: “I'm…

Jan 16, 2025, 22:19 | Blog

Don’t miss the ESMO Sarcoma and Rare Cancers Congress 2025!

ESMO shared on LinkedIn: "Don’t miss the ESMO Sarcoma and Rare Cancers Congress 2025! Join top…

Jan 15, 2025, 15:12 | Insight

Taha Koray Sahin: First meeting of the ESMO Virtual Mentorship Programme

Taha Koray Sahin, Medical Oncologist at Hacettepe University, shared on X: “First meeting of the…

Jan 13, 2025, 17:20 | Blog

Abstract submission is open for ESMO Breast Cancer 2025

ESMO posted on LinkedIn: "Be part of something big and present your research in front…

Jan 13, 2025, 11:50 | Oncolibrary,Oncologist Near Me

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Welcome to OncoDaily’s special section “Oncologist Near Me”, where we introduce prominent oncologists from around…

Jan 11, 2025, 14:17 | Opinion

Dario Trapani about the importance of a value-based approach to Oncology Innovation - ESMO

ESMO shared a post on X: “The value of therapy isn’t just life extension; it…

Jan 11, 2025, 08:42 | Blog

Christina H. Ruhlmann: Assessing the current management of immune-related adverse events

Christina H. Ruhlmann, Associate Professor at OUH Odense University Hospital, shared a post on LinkedIn:…

Jan 10, 2025, 17:16 | Insight

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

As the Head of the Research Division at Gustave Roussy Cancer Campus in France, Professor…

Jan 9, 2025, 12:05 | Blog

Burnout has been identified as a major concern in oncology

ESMO posted on LinkedIn: "ESMO for Carers: Burnout has been identified as a major concern…

Jan 9, 2025, 10:48 | Blog

ONE week left to submit your work for ELCC 2025 - ESMO

ESMO shared a post on LinkedIn: “The countdown is on! There's only ONE week left…

Jan 7, 2025, 16:43 | Insight

Manoj Reddy: The Role of AI in Radiation Oncology

Manoj Reddy, Founder and President of IOWG, shared a post on LinkedIn: "The Role of…

Jan 7, 2025, 12:38 | Blog

Herbert Loong: Sarcoma Updates from ESMO 2024

Herbert Loong, Associate Professor in the Department of Clinical Oncology at The Chinese University of…

Jan 6, 2025, 09:27 | Blog

Erman Akkus: What is your daily practice for molecular testing in pancreatic cancer?

Erman Akkus, Medical Oncology fellow at Ankara University, Faculty of Medicine, shared a post on…

Jan 5, 2025, 17:14 | Blog

Recent findings consolidate the role of Liquid Biopsy in the field of immunotherapy - ESMO

ESMO (European Society for Medical Oncology) shared a post on LinkedIn: "Management of Advanced Solid…

Jan 5, 2025, 16:00 | Career

Giuseppe Curigliano: I have a new job position - ESMO President Elect

Giuseppe Curigliano, ESMO President-Elect and Open Editor in Chief shared a post on LinkedIn: "I…

Jan 5, 2025, 13:29 | Science

Daniel Michaeli: How could patients and payers save $3 billion on cancer drugs?

Daniel Michaeli, a Medical Doctor at the National Center for Tumor Diseases (NCT) Heidelberg, shared…

Jan 4, 2025, 15:35 | Science

Aris Angelis: The use of the ESMO MCBS for coverage and reimbursement decisions of cancer medicines

Aris Angelis, Secretary General for Strategic Planning at Greek Ministry of Health, shared a post…

Dec 31, 2024, 07:46 | Blog

Emad Shash: Reflection on 2024 - A Year of Growth, Achievements and Resilience

Emad Shash, General Manager of the Breast Cancer Comprehensive Center of the NCI at Cairo…

Dec 30, 2024, 07:34 | Blog

National Center for Cancer Immune Therapy of Denmark at ESMO Immuno-Oncology Congress 2024

CCIT-DK - National Center for Cancer Immune Therapy of Denmark shared a post on LinkedIn:…

Dec 28, 2024, 18:11 | Blog

Hesham A. Abdullah: 2024 has been a momentous year for GSK Oncology

Hesham A. Abdullah, Senior Vice President of Global Head Oncology, Research and Development at GSK…

Dec 22, 2024, 17:51 | Insight

Angela Lamarca: eUpdate of ESMO Biliary Malignancies CP Guidelines

Angela Lamarca, HPB and NET Medical Oncologist at Jimenez Diaz Foundation, shared a post on…

Dec 22, 2024, 13:11 | Blog

Akhil Santhosh: Important changes in the latest ESMO BTC guidelines

Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre & Research Institute, shared a post…

Dec 22, 2024, 04:52 | Blog

Registration is open for the ESMO Gastrointestinal Cancers Congress 2025

ESMO (European Society for Medical Oncology) shared a post on LinkedIn: "We’re excited to announce…

Dec 21, 2024, 18:14 | Blog

Benedikt Westphalen: Announcing the ESMO Precision Oncology Working Group

Benedikt Westphalen, Medical Lead of Precision Oncology at CCC München – Comprehensive Cancer Center, shared…

Dec 21, 2024, 13:51 | Blog

The ESMO President Letter emphasises the importance of collective action to shape the future of oncology

ESMO shared on LinkedIn: "The ESMO President Letter is now available. As his term comes to…

Dec 21, 2024, 13:43 | Blog

National University Cancer Institute, Singapore clinicians had the exciting opportunity to present their work at the ESMO Asia 2024

National University Cancer Institute, Singapore shared on LinkedIn: "Earlier this month, our clinicians had the exciting…

Dec 21, 2024, 13:05 | Cancer Types

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Esophageal cancer is a malignant condition arising from the lining of the esophagus, the muscular…

Dec 21, 2024, 03:28 | Blog

Valerie Yang: A fantastic meeting of minds at the recently concluded ESMO Asia 2024

Valerie Yang, Consultant at the National Cancer Centre Singapore, shared a post on LinkedIn: "A…

Dec 20, 2024, 13:41 | Blog

Zarina Othman: Amazing numbers for ESMO Asia24

Zarina Othman, Head of Asia Region Operations at ESMO, shared a post by ESMO (European…

Dec 19, 2024, 17:49 | Blog

Countdown to the Sarcoma and Rare Cancers Congress 2025 - ESMO

ESMO – European Society for Medical Oncology posted the following on LinkedIn: “The countdown to…

Dec 19, 2024, 17:05 | Blog

Juan W. Valle: ESMO updates BTC guidelines for advanced care

Juan W. Valle, Chief Medical Officer at Cholangiocarcinoma Foundation, posted the following on LinkedIn: “The updated…

Dec 19, 2024, 16:53 | Blog

Giuseppe Curigliano: Great pleasure to host Prof. Humaid Al-Shamsi

Giuseppe Curigliano, Director of the Early Drug Development Division and co-chairs the Experimental Therapeutics Program at…

Dec 19, 2024, 14:01 | Blog

The ESMO Asia Congress 2024 was a milestone in advancing oncology research and treatment in Asia-Pacific

ESMO shared on LinkedIn: "The ESMO Asia Congress 2024 brought together 4,300 professionals from 68…

Dec 19, 2024, 12:33 | Science

Sacituzumab govitecan vs platinum-based chemotherapy for Urothelial Carcinoma - ESMO

ESMO posted on X about recent paper by Petros Grivas et al., titled "LBA9 TROPiCS-04,…

Dec 19, 2024, 12:01 | Insight

Remon Jordi Discusses Advances in Thoracic Oncology at ESMO Asia 2024

Mediamedic shared a post on LinkedIn: “ESMO Asia 2024, Jordi Remon Masip Highlights Key Thoracic…

Dec 19, 2024, 11:54 | Opinion

Lung Cancer Trial Highlights from 2024 By Yakup Ergün

Yakup Ergün, Medical Oncologist at Antalya City Hospital, posted on X: “What happened in Lung…

Dec 19, 2024, 08:27 | Insight

What role does mentorship play in building resilience? - ESMO

ESMO - European Society for Medical Oncology shared a post on LinkedIn: “ESMO4Carers: What role…

Dec 18, 2024, 16:11 | Blog

Paolo Tarantino: Proud to be part of international group of ESMO Ambassadors

Paolo Tarantino, PhD in clinical research at the University of Milan, shared a post on…

Dec 18, 2024, 15:49 | Insight

ESMO Clinical Practice Guideline eUpdate on Biliary Tract Cancer

ESMO - European Society for Medical Oncology shared a post on LinkedIn: “ESMO Clinical Practice…

Dec 18, 2024, 13:26 | Science

Marco Donia: Uncovering the Immunological Dynamics of MHC class II in Melanoma

Marco Donia, Senior Consultant at the University of Copenhagen Herlev Hospital, shared a post on…

Dec 17, 2024, 23:36 | Blog

ESMO Ambassadors reporting on the latest Cancer Research in the past year from ESMO events

ESMO - European Society for Medical Oncology shared a post on LinkedIn: "The ESMO Ambassadors…

Dec 17, 2024, 23:36 | Blog

Ravindran Kanesvaran: Evidence-based ESMO guidelines for Asian populations

Ravindran Kanesvaran, Chairman of the Division of Medical Oncology at the National Cancer Centre Singapore,…

Dec 16, 2024, 16:12 | Blog

ESMO survey on access to medicines

Dario Trapani, Medical Oncologist at the European Institute of Oncology, reshared a post by The…

Dec 15, 2024, 09:36 | Blog

Essential Insights for Clinicians: ESMO's 2nd edition on Breast Cancer Highlights Key Patients-Centric Strategies

ESMO posted on LinkedIn: "ESMO members: have you downloaded Breast Cancer: Essentials for Clinicians (2nd…

Dec 15, 2024, 08:35 | Blog

Sami (Papacek) Mansfield: Sharing lifestyle research and implementation in the Cancer Matters

Sami (Papacek) Mansfield, Founder of Cancer Wellness for Life and also a Chair of Cancer…

Dec 14, 2024, 15:57 | Insight

Shubham Pant: Updated data from the Phase 1 AMPLIFY-201 trial at the ESMO

Shubham Pant, Professor in the Department of Gastrointestinal Medical Oncology at The University of Texas…

Dec 14, 2024, 13:43 | Blog

Nina Niu Sanford: BCLC, can we be friends?

Nina Niu Sanford, Assistant Professor and Chief of Gastrointestinal Radiation Oncology at Harvard/Brigham and Women’s…

Dec 14, 2024, 07:01 | Societies

2025 ESMO AI and Digital Oncology Annual Congress

ESMO shared on LinkedIn: “Serving as a central hub for the latest research, ethical discussions…

Dec 13, 2024, 16:16 | Blog

ESMO - Neoadjuvant immunotherapy sets a new standard in stage III melanoma

ESMO shared on LinkedIn: "More than 40% of patients with resectable stage III melanoma experience disease…

Dec 12, 2024, 20:39 | Blog

ESMO - RCTs have been instrumental in establishing immunotherapy with ICIs for treating Advanced Solid Cancer

ESMO shared on LinkedIn: "ESMOImmuno24: Randomised controlled trials (RCTs) have been instrumental in establishing immunotherapy with…

Dec 12, 2024, 20:33 | Blog

Yakup Ergün: ESMO Magnitude of Clinical Benefit Scale

Yakup Ergün, Medical Oncologist at Bower Hospital, shared a post on X: "European Society for…

Dec 12, 2024, 16:15 | Blog

In 2022, Annals Of Oncology transitioned to an online-only format - ESMO

ESMO - European Society for Medical Oncology shared a post on LinkedIn: “In 2022, Annals…

Dec 12, 2024, 13:21 | Insight

Nicole Charbel: Examining the effect of spirituality on the quality of life amongst patients with Cancer

Nicole Charbel, Postdoctoral Research Fellow in the Hematology/Oncology Department at American University of Beirut, shared…

Dec 12, 2024, 11:55 | Blog

Jonathan Lim: Applications open for ICF-ESMO Clinical Unit Visit Fellowship

Jonathan Lim, Clinical Senior Lecturer in Cancer Biology at The University of Manchester, shared a…

Dec 11, 2024, 17:30 | Blog

Herbert Loong: The status of early Lung Cancer detection and screening in the Asia Pacific region

Herbert Loong, Associate Professor in the Department of Clinical Oncology at The Chinese University of…

Dec 11, 2024, 14:33 | Blog

The importance of science and artistry in Radiotherapy planning in NPC

Melvin LK Chua, Head of the Department of Head Neck and Thoracic Cancers, Division of…

Dec 11, 2024, 10:33 | Blog

Pemetrexed plus platinum ± pembrolizumab in untreated metastatic nonsquamous NSCLC

ESMO shared on X: "For Annals of Oncology Anniversary we highlight this 2023 top-cited paper:' Pemetrexed…

Dec 11, 2024, 09:53 | Insight

Thomas Powles was appointed Editor-in-Chief of Annals of Oncology

Thomas Powles was appointed the Editor-in-Chief of Annals of Oncology in early 2024. Thomas Powles,…

Dec 10, 2024, 19:27 | Blog

Herbert Loong: Successful 3 days of education interactions and collaborations building at ESMOAsia24

Herbert Loong, Associate Professor in the Department of Clinical Oncology at The Chinese University of…

Dec 10, 2024, 18:43 | Insight

'Men and Cancer: Improving Outcomes, Saving Lives' at ESMO Asia Congress 2024 - ECO

European Cancer Organisation shared on LinkedIn: “On 6 December, we participated in a crucial roundtable…

Dec 10, 2024, 17:32 | Blog

Targeting claudins in pancreatic cancer shows promise - ESMO

ESMO - European Society for Medical Oncology posted the following on LinkedIn: “IBI343, an anti-claudin…

Dec 10, 2024, 17:04 | Blog

Han Chong Toh: The greatest gathering of GI cancer leaders

Han Chong Toh, Deputy CEO of the National Cancer Centre Singapore, shared a post by…

Dec 10, 2024, 16:19 | Blog

Three new Pan-Asian-adapted guidelines at ESMO Asia Congress - ESMO

ESMO - European Society for Medical Oncology posted the following on LinkedIn: “From the collaboration…

Dec 10, 2024, 06:59 | Blog

Teresa Amaral: The fantastic group of the ESMO LGP Asia edition 2023-2024

Teresa Amaral, Head of Skin Cancer Clinical Trials Center at University Hospital Tübingen, shared a…

Dec 10, 2024, 06:32 | Blog

Addressing Asia-specific challenges and pioneering new solutions at ESMO Asia 2024

ESMO - European Society for Medical Oncology shared a post on LinkedIn: "Thank you for…

Dec 10, 2024, 05:50 | Blog

Andrew Parsonson: DB-1311 shows encouraging activity and safety in multiple tumours

Andrew Parsonson, Medical Oncologist, Macquarie University Clinical Associates, shared a post on X: “DB-1311 (B7-H3…

Dec 9, 2024, 18:57 | Blog

Florian Lordick: Had excellent teaching, discussion and networking at the ESMO Preceptorship for Gastric Cancer

Florian Lordick, Professor of Medicine at the University of Leipzig, shared a post on LinkedIn:…

Dec 9, 2024, 18:01 | Blog

Prashant Kumar: Privileged to have been chosen for the Best Poster Award at the Prestigious ESMO Asia 2024

Prashant Kumar, Chief Scientific Officer of Datar Cancer Genetics, shared a post on LinkedIn: "I…

Dec 9, 2024, 13:43 | Blog

Drew Moghanaki: The phase III KEYNOTE-867 study results at ESMO 2024

Drew Moghanaki, Professor and Chief of Thoracic Oncology at the Department of Radiation Oncology, shares…

Dec 9, 2024, 13:36 | Blog

Zhen Su: Overcome PD-1 Resistant in Solid Tumor with a Novel Dual T-cell Agonist approach

Zhen Su, CEO at Marengo Therapeutics, shared a post on LinkedIn: "Overcome PD-1 resistant in…

Dec 8, 2024, 07:13 | Blog

Petros Grivas: Great to present TROPiCS04 trial at ESMOAsia24

Petros Grivas, Clinical Director of the Genitourinary Cancers Program at the University of Washington, reshared…

Dec 8, 2024, 07:10 | Blog

Angela Lamarca: MO138 in Biliary Cancer at ESMOAsia24 by Lorenza Rimassa

Angela Lamarca, HPB and NET Medical Oncologist at Jimenez Diaz Foundation, shared a post on…

Dec 8, 2024, 05:30 | Insight

Brittney Abernathy: My first time at ESMO Asia

Brittney Abernathy, Journal Manager for Frontiers in Cancer Control and Society and Oncology Reviews, shared…

Dec 8, 2024, 05:13 | Insight

Angela Lamarca: Update form CHECKMATE-9DW trial in HCC - Asian population with Ipilimumab and nivolumab

Angela Lamarca, HPB and NET Medical Oncologist at Jimenez Diaz Foundation, shared a post on…

Dec 8, 2024, 04:47 | Insight

Exciting developments in the management of unresectable stage III EGFR NSCLC

Aakash Desai, Assistant Professor and Associate Director at UAB O'Neal Comprehensive Cancer Center, shared an…

Dec 8, 2024, 03:55 | Blog

ESMO Membership Value Survey

ESMO - European Society for Medical Oncology shared a post on LinkedIn: "ESMO Membership value…

Dec 7, 2024, 14:41 | Blog

Highlights from ESMO Asia 2024 by Angela Lamarca

The ESMO Asia Congress 2024 is currently taking place from December 6 to 8, 2024,…

Dec 7, 2024, 10:48 | Insight

Use of the ESMO-Magnitude of Clinical Benefit Scale for HTA Recommendations

Fabrice Andre shared a post on X: "One key mission of ESMO is to deliver Frameworks…

Dec 7, 2024, 10:09 | Insight

Matteo Lambertini Reflects on ESMO Breast Cancer Preceptorship in Singapore

Matteo Lambertini, Adjunct professor and consultant in medical oncology at the IRCCS Policlinico San Martino…

Dec 7, 2024, 03:06 | Insight

Neoadjuvant Chemotherapy plus Immune Checkpoint Inhibitors in Gastroesophageal Cancers

Erman Akkus, Medical Oncology Fellow at Ankara University, shared a recent article by A. Cammarota…

Dec 6, 2024, 14:59 | Positive

Teresa Amaral: Family photo before the graduation ceremony of the ESMOLGPASIA program

Teresa Amaral shared on LinkedIn: "The happy family photo before the graduation ceremony of the…

Dec 6, 2024, 10:10 | Blog

New ESMO Clinical Practice Guideline recommendations in Advanced Colorectal Cancer

ESMO - European Society for Medical Oncology shared a post on LinkedIn: " New ESMO…

Dec 5, 2024, 15:37 | Insight

Two top-cited 2023 papers on Annals Of Oncology - ESMO

ESMO shared on LinkedIn: "As Annals Of Oncology 35th Anniversary is commemorated, here are two…

Dec 5, 2024, 15:18 | Blog

Matteo Lambertini: The use of genomic testing in early HR+/HER2- disease

Matteo Lambertini, Adjunct professor and consultant in medical oncology at the IRCCS Policlinico San Martino…

Dec 4, 2024, 18:55 | Blog

Jarushka Naidoo: Join the ESMO Immuno24 next week in Geneva

Jarushka Naidoo shared a post by ESMO on X: "Join us for ESMO Immuno24 next week…

Dec 4, 2024, 18:30 | Blog

Women for Oncology Forum at ESMO Asia 2024

ESMO posted on LinkedIn: "ESMO Asia24: Do not miss the ESMO Women for Oncology Forum…

Dec 4, 2024, 14:08 | Blog

Matteo Lambertin: Exciting to start the ESMO preceptorship on Breast Cancer with Rebecca Dent

Matteo Lambertin, Associate Professor at University of Genoa and Medical Oncologist at San Martino Hospital…

Dec 4, 2024, 10:39 | Insight

Elisa Agostinetto: The Results of the NEOENDO Translational Study by Francesco Schettini, et al.

Elisa Agostinetto, Medical Research Fellow at the University Hospital of Brussels, shared an article by…

Dec 4, 2024, 09:54 | Positive

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Starting on August 26, in honor of Women’s Equality Day in the United States, which…

Dec 4, 2024, 00:00 | Blog

ESMO - Practice-changing publications in NSCLC and endometrial cancer critically reviewed by leading experts

ESMO shared on LinkedIn: " Practice-changing publications in NSCLC (LAURA trial) and endometrial cancer (RUBY trial)…

Dec 3, 2024, 18:00 | Blog

Annals of Oncology Impact factor surpassed 10 in 2017 - ESMO

ESMO - European Society for Medical Oncology posted the following on LinkedIn: “Milestones Monday Annals…

Dec 3, 2024, 14:29 | Blog

ESMO - In 2014, Jean-Charles Soria became the youngest Editor-in-Chief in the journal's history

ESMO shared on LinkedIn: "Milestones Monday: In 2014, Jean-Charles Soria became the youngest Editor-in-Chief in the…

Dec 2, 2024, 10:01 | Blog

Women, Power, and Cancer: my latest interview with ecancer - Ophira Ginsburg

Ophira Ginsburg, the Senior Scientific Officer and Senior Advisor for Clinical Research at the US…

Dec 2, 2024, 09:46 | Positive

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

As November came to a close, it's an ideal time to reflect on Lung Cancer…

Dec 1, 2024, 21:13 | Blog

Jean-Charles Soria's discussion about Annals Of Oncology's evolution and its impact on oncology - ESMO

ESMO - European Society for Medical Oncology shared a post on LinkedIn: "To mark the…